Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts that cover Viridian Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $35.77, which forecasts a 109.92% increase in the stock price over the next year. The lowest target is $20 and the highest is $61.

Price Target: $35.77 (+109.92%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$35.77	$33	$61
Change	+17.37%	+109.92%	+93.66%	+257.98%

Analyst Ratings

The average analyst rating for Viridian Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	5	6	6	6	6	6
Buy	6	6	6	6	7	7
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	13	13	13	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lisa Walter RBC Capital	RBC Capital	Buy Maintains $30 → $34	Buy	Maintains	$30 → $34	+99.53%	May 6, 2026
Serge Belanger Needham	Needham	Strong Buy Reiterates $32	Strong Buy	Reiterates	$32	+87.79%	May 5, 2026
Gregory Renza Truist Securities	Truist Securities	Strong Buy Maintains $36 → $33	Strong Buy	Maintains	$36 → $33	+93.66%	Apr 21, 2026
Laura Chico Wedbush	Wedbush	Buy Maintains $37 → $31	Buy	Maintains	$37 → $31	+81.92%	Apr 8, 2026
Richard Law Goldman Sachs	Goldman Sachs	Strong Buy Maintains $36 → $31	Strong Buy	Maintains	$36 → $31	+81.92%	Apr 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

69.10M

Decreased by -2.47%

from 70.85M

Revenue Next Year

287.55M

Increased by 316.15%

from 69.10M

EPS This Year

-4.12

from -3.32

EPS Next Year

-2.45

from -4.12

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.96M	1.77M	314.00K	302.00K	70.85M	69.10M	287.55M
Revenue Growth	182.19%	-40.20%	-82.28%	-3.82%	23,359.93%	-2.47%	316.15%
EPS	-6.66	-2.71	-3.91	-3.07	-3.32	-4.12	-2.45
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	217.7M	665.2M
Avg	69.1M	287.6M
Low	14.8M	131.3M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	207.2%	862.7%
Avg	-2.5%	316.1%
Low	-79.1%	90.0%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	-2.87	-0.76
Avg	-4.12	-2.45
Low	-4.85	-4.83

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.